MY182395A - Recombinase mutants - Google Patents
Recombinase mutantsInfo
- Publication number
- MY182395A MY182395A MYPI2017701081A MYPI2017701081A MY182395A MY 182395 A MY182395 A MY 182395A MY PI2017701081 A MYPI2017701081 A MY PI2017701081A MY PI2017701081 A MYPI2017701081 A MY PI2017701081A MY 182395 A MY182395 A MY 182395A
- Authority
- MY
- Malaysia
- Prior art keywords
- recombinase
- improved
- recombinase mutants
- amplification
- mutants
- Prior art date
Links
- 102000018120 Recombinases Human genes 0.000 title abstract 3
- 108010091086 Recombinases Proteins 0.000 title abstract 3
- 230000003321 amplification Effects 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
- C12Y306/01008—ATP diphosphatase (3.6.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/501—Ligase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462057056P | 2014-09-29 | 2014-09-29 | |
| PCT/US2015/053012 WO2016054088A1 (en) | 2014-09-29 | 2015-09-29 | Recombinase mutants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY182395A true MY182395A (en) | 2021-01-23 |
Family
ID=54293382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2017701081A MY182395A (en) | 2014-09-29 | 2015-09-29 | Recombinase mutants |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9982244B2 (enExample) |
| EP (1) | EP3201222B1 (enExample) |
| JP (2) | JP2017529093A (enExample) |
| KR (3) | KR20170065028A (enExample) |
| CN (1) | CN107208075B (enExample) |
| AU (1) | AU2015323936B2 (enExample) |
| BR (1) | BR112017006542B1 (enExample) |
| CA (1) | CA2962941C (enExample) |
| DK (1) | DK3201222T3 (enExample) |
| ES (1) | ES2729302T3 (enExample) |
| IL (1) | IL251422B (enExample) |
| MX (1) | MX385063B (enExample) |
| MY (1) | MY182395A (enExample) |
| NZ (1) | NZ730593A (enExample) |
| RU (1) | RU2721920C2 (enExample) |
| SG (1) | SG11201702493WA (enExample) |
| WO (1) | WO2016054088A1 (enExample) |
| ZA (1) | ZA201702248B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017529093A (ja) * | 2014-09-29 | 2017-10-05 | イルミナ ケンブリッジ リミテッド | リコンビナーゼ変異体 |
| WO2017172699A1 (en) * | 2016-03-28 | 2017-10-05 | Illumina, Inc. | Recombinase mutants |
| JP7048609B2 (ja) * | 2016-12-09 | 2022-04-05 | ボリアル ジェノミクス， インコーポレイテッド | 連結型ライゲーション |
| GB201704754D0 (en) | 2017-01-05 | 2017-05-10 | Illumina Inc | Kinetic exclusion amplification of nucleic acid libraries |
| CN108913700B (zh) * | 2018-08-16 | 2021-04-09 | 深圳市艾伟迪生物科技有限公司 | gp32单链结合蛋白的制备方法、表达基因、重组表达载体及应用 |
| CN115975956A (zh) * | 2022-02-23 | 2023-04-18 | 杨挥 | 一种重组酶突变体及包含该突变体的核酸等温扩增反应体系 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223414A (en) | 1990-05-07 | 1993-06-29 | Sri International | Process for nucleic acid hybridization and amplification |
| US8030000B2 (en) | 2002-02-21 | 2011-10-04 | Alere San Diego, Inc. | Recombinase polymerase amplification |
| DK1499738T3 (da) | 2002-02-21 | 2008-11-17 | Asm Scient Inc | Recombinase-polymerease-amplifikation |
| US7399590B2 (en) | 2002-02-21 | 2008-07-15 | Asm Scientific, Inc. | Recombinase polymerase amplification |
| US6897069B1 (en) | 2004-06-08 | 2005-05-24 | Ambion, Inc. | System and method for electroporating a sample |
| EP2829615B1 (en) | 2005-07-25 | 2018-05-09 | Alere San Diego, Inc. | Kit for multiplexing recombinase polymerase amplification |
| US7742463B2 (en) | 2005-08-18 | 2010-06-22 | Hong Kong Applied Science And Technology Research Institute Co., Ltd. | Security gatekeeper for a packetized voice communication network |
| EP2029782B1 (en) * | 2006-05-04 | 2014-11-26 | Alere San Diego, Inc. | Recombinase polymerase amplification |
| WO2010141940A1 (en) * | 2009-06-05 | 2010-12-09 | Alere San Diego, Inc. | Recombinase polymerase amplification reagents and kits |
| CN103153960B (zh) | 2010-09-21 | 2015-02-25 | 巴斯夫欧洲公司 | 制备取代的n-苯基羟胺的方法 |
| EP3978620A1 (en) * | 2011-04-07 | 2022-04-06 | Abbott Diagnostics Scarborough, Inc. | Monitoring recombinase polymerase amplification mixtures |
| US8895249B2 (en) | 2012-06-15 | 2014-11-25 | Illumina, Inc. | Kinetic exclusion amplification of nucleic acid libraries |
| JP2017529093A (ja) * | 2014-09-29 | 2017-10-05 | イルミナ ケンブリッジ リミテッド | リコンビナーゼ変異体 |
-
2015
- 2015-09-29 JP JP2017516936A patent/JP2017529093A/ja active Pending
- 2015-09-29 CN CN201580059870.9A patent/CN107208075B/zh active Active
- 2015-09-29 RU RU2017110582A patent/RU2721920C2/ru active
- 2015-09-29 KR KR1020177011954A patent/KR20170065028A/ko not_active Ceased
- 2015-09-29 AU AU2015323936A patent/AU2015323936B2/en active Active
- 2015-09-29 US US14/869,744 patent/US9982244B2/en active Active
- 2015-09-29 SG SG11201702493WA patent/SG11201702493WA/en unknown
- 2015-09-29 DK DK15779119.5T patent/DK3201222T3/da active
- 2015-09-29 ES ES15779119T patent/ES2729302T3/es active Active
- 2015-09-29 EP EP15779119.5A patent/EP3201222B1/en active Active
- 2015-09-29 KR KR1020197008943A patent/KR102126641B1/ko active Active
- 2015-09-29 KR KR1020207006203A patent/KR20200026320A/ko not_active Ceased
- 2015-09-29 MX MX2017004034A patent/MX385063B/es unknown
- 2015-09-29 MY MYPI2017701081A patent/MY182395A/en unknown
- 2015-09-29 BR BR112017006542-8A patent/BR112017006542B1/pt active IP Right Grant
- 2015-09-29 NZ NZ730593A patent/NZ730593A/en unknown
- 2015-09-29 CA CA2962941A patent/CA2962941C/en active Active
- 2015-09-29 WO PCT/US2015/053012 patent/WO2016054088A1/en not_active Ceased
-
2017
- 2017-03-27 IL IL251422A patent/IL251422B/en active IP Right Grant
- 2017-03-30 ZA ZA2017/02248A patent/ZA201702248B/en unknown
-
2018
- 2018-05-11 US US15/977,389 patent/US10344269B2/en active Active
-
2019
- 2019-08-02 JP JP2019143116A patent/JP6879519B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Single-cell sequencing technologies: current and future | |
| WO2014144761A3 (en) | Increasing specificity for rna-guided genome editing | |
| WO2016196765A3 (en) | Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies | |
| SG10201804715WA (en) | Crispr hybrid dna/rna polynucleotides and methods of use | |
| WO2016057951A3 (en) | Crispr oligonucleotides and gene editing | |
| WO2015161054A3 (en) | Methods and systems for nucleic acid amplification | |
| WO2017139505A3 (en) | Methods and compositions for modifying a mutant dystrophin gene in a cell's genome | |
| WO2018175636A3 (en) | Compositions and methods for immunooncology | |
| SG10201810150UA (en) | Compositions and methods for enhanced gene expression in cone cells | |
| EP4219744A3 (en) | Methods of preparing nucleic acids for sequencing | |
| EP4582556A3 (en) | Methods and compositions for whole transcriptome amplification | |
| WO2014165825A3 (en) | Therapeutic uses of genome editing with crispr/cas systems | |
| EP3161127A4 (en) | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof | |
| MX385063B (es) | Mutantes de recombinasas. | |
| WO2016161169A3 (en) | Cell culture incubators with integrated cell manipulation systems | |
| WO2017172645A3 (en) | Bacteriophage engineering methods | |
| GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
| EP3750907A3 (en) | Raav-based compositions and methods for treating amyotrophic lateral sclerosis | |
| WO2015196128A3 (en) | Alternative nucleic acid molecules and uses thereof | |
| WO2015196130A3 (en) | Alternative nucleic acid molecules and uses thereof | |
| EP4464338A3 (en) | Systems for improving crispr/cas-mediated genome-editing | |
| WO2015013465A3 (en) | Methods and compositions for detecting bacterial contamination | |
| GB201609811D0 (en) | Methods, cells, systems, arrays, RNA and kits | |
| WO2015149034A3 (en) | Gene fusions and gene variants associated with cancer | |
| MX2019004156A (es) | Variantes de endonucleasa homing de receptor de linfocitos t alfa (tcralpha). |